Latest Breaking News On - Hong kong integrated oncology center - Page 1 : vimarsana.com

An acquisition in Hong Kong by the New Frontier Group, an IPO by Sunho Biologics on the HKEX and a $1.5bn investment into Singapore by AstraZeneca, are signs that investments in next generation cancer treatments are increasing in the region.

Hong kongUnited kingdomUnited statesSuno biologicsGarri zmudzeSunho biologicsPureos bioventuresAsia pacificJohn leeWorld health organisationHong kong integrated oncology centerTechnology innovation zoneSingapore economic development boardHong kong stock exchangeHaymarket mediaAsia summit on global health